These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4623096)

  • 41. Combined hydergin and pantesin therapy of acute apoplexies, its sequelae, and diffuse sclerotic encephalopathies.
    Boganelli I; Scardigli G; Memeo SA
    G Gerontol; 1966 Dec; 14(12):1163-8. PubMed ID: 4966652
    [No Abstract]   [Full Text] [Related]  

  • 42. An ergot preparation (hydergine) in the treatment of cerebrovascular disorders in the geriatric patient: double-blind study.
    Ditch M; Kelly FJ; Resnick O
    J Am Geriatr Soc; 1971 Mar; 19(3):208-17. PubMed ID: 4998602
    [No Abstract]   [Full Text] [Related]  

  • 43. [Clinical aspects on the therapy of cerebral sclerosis].
    Hoffmeister K
    Med Klin; 1967 Jun; 62(23):910-2. PubMed ID: 4970034
    [No Abstract]   [Full Text] [Related]  

  • 44. [Therapy of cerebral ictus yesterday and today].
    Giorgini R
    Minerva Med; 1974 Mar; 65(24):1316-21. PubMed ID: 4133959
    [No Abstract]   [Full Text] [Related]  

  • 45. [Analysis of the effect of Hydergin in long-term trial. An interdisciplinary study].
    Herzfeld U; Christian W; Oswald WD; Ronge J; Wittgen M
    Med Klin; 1972 Sep; 67(35):1118-25. PubMed ID: 4627270
    [No Abstract]   [Full Text] [Related]  

  • 46. Use of an ergot preparation (hydergine) in the convalescent phase of stroke.
    Bochner F; Eadie MJ; Tyrer JH
    J Am Geriatr Soc; 1973 Jan; 21(1):10-7. PubMed ID: 4630036
    [No Abstract]   [Full Text] [Related]  

  • 47. An ergot alkaloid preparation (Hydergine) versus papaverine in treating common complaints of the aged: double-blind study.
    Bazo AJ
    J Am Geriatr Soc; 1973 Feb; 21(2):63-71. PubMed ID: 4631704
    [No Abstract]   [Full Text] [Related]  

  • 48. [Hydergine in the treatment of chronic psychoses].
    Bohard F; Guennoc A; Klein H; Le Borgne Y; Masanes P
    Ann Med Psychol (Paris); 1967 Mar; 125(3):438-46. PubMed ID: 4964710
    [No Abstract]   [Full Text] [Related]  

  • 49. [Prolonged treatment of psycho-character disorders in the hospitalized aged with the combination of dihydroderivatives of secale cornutum and thioridazine].
    Alessandrini A; Tiberi F
    Clin Ter; 1971 Jul; 58(1):57-65. PubMed ID: 5003303
    [No Abstract]   [Full Text] [Related]  

  • 50. Sinus bradycardia following treatment with hydergine for cerebrovascular insufficiency.
    Dcayley AC; Macpherson A; Wedgwood J
    Br Med J; 1975 Nov; 4(5993):384-5. PubMed ID: 811310
    [No Abstract]   [Full Text] [Related]  

  • 51. [Effect of raubasine and dihydroergocristine on arteriosclerotic and hypertensive cerebral diseases].
    Klein K
    Vasa; 1973; 2(4):409-14. PubMed ID: 4202492
    [No Abstract]   [Full Text] [Related]  

  • 52. [Therapy of acute cerebrovascular insufficiency].
    Volles E
    Dtsch Med Wochenschr; 1973 Jan; 98(3):123. PubMed ID: 4630687
    [No Abstract]   [Full Text] [Related]  

  • 53. [Headaches in patients with vascular deficiency and their treatment with a raubasine-dihydroergocristine association].
    Henry P
    Bord Med; 1972 Nov; 5(18):2531-4. PubMed ID: 4196611
    [No Abstract]   [Full Text] [Related]  

  • 54. Influence of treatment on symptomatology and correlated electroencephalographic (EEG) changes in the aged.
    Arrigo A; Braun P; Kauchtschischwili GM; Moglia A; Tartara A
    Curr Ther Res Clin Exp; 1973 Jul; 15(7):417-26. PubMed ID: 4198303
    [No Abstract]   [Full Text] [Related]  

  • 55. Electroencephalogram and ergot alkaloids.
    Venn RD
    Postgrad Med J; 1976; 52suppl 1():55-6. PubMed ID: 822408
    [No Abstract]   [Full Text] [Related]  

  • 56. [Clinical effects of the DHR-1015 compound in the treatment of arterial hypertension].
    Sáez Causillas A
    Rev Clin Esp; 1968 Oct; 111(2):191-8. PubMed ID: 4980458
    [No Abstract]   [Full Text] [Related]  

  • 57. [Combined treatment with hydergine and neuroleptics in mental disorders of old age].
    Bukowczyk A; Wasik A; Horodnicki J
    Psychiatr Pol; 1969; 3(3):327-32. PubMed ID: 4980081
    [No Abstract]   [Full Text] [Related]  

  • 58. [Therapeutic effect of Sandoven in chronic venous insufficiency].
    Horáková-Nedvídková M; Figar S
    Cas Lek Cesk; 1970 Jul; 109(36):839-43. PubMed ID: 4989549
    [No Abstract]   [Full Text] [Related]  

  • 59. [Clinical treatment of symptoms of veinous insufficiency symptoms with Sandoven].
    Obeid-Ruggli V; Probst G
    Schweiz Rundsch Med Prax; 1971 Sep; 60(37):1247-50. PubMed ID: 4999377
    [No Abstract]   [Full Text] [Related]  

  • 60. [How to treat a stroke].
    Arné L
    J Med Bord; 1967 Jun; 144(6):869-73. PubMed ID: 4980447
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.